摘要
《中国血脂管理指南(2023年)》于2023年3月重磅发布,引发了广泛关注。与《中国成人血脂异常防治指南(2016年)》相比,新指南在诸多方面做了更新,其中强化降脂和联合用药两个方面值得关注。新指南的更新为临床进一步降低血脂异常患者心血管事件风险提供了可靠指导。
Chinese guidelines for lipid management(2023)were released in March this year,which attracted widespread attention.Compared with the"Guidelines for the Prevention and Treatment of Dyslipidemia in Chinese Adults(2016)",the new guidelines have been updated in many aspects,among which"intensive lipid reduction"and"combination medication"are worthy of attention.The updated guidelines provide reliable guidance for further reducing the risk of cardiovascular events in patients with dyslipidemia.
作者
黄坤
程翔
廖玉华
HUANG Kun;CHENG Xiang;LIAO Yuhua(Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,China)
出处
《临床心血管病杂志》
CAS
北大核心
2023年第5期340-341,共2页
Journal of Clinical Cardiology
关键词
血脂管理
中国血脂管理指南
lipid management
Chinese guidelines for lipid management(2023)
